<!DOCTYPE html>
<html>
  <head>
    <title>Abnormal Uterine Bleeding</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootstrap/3.2.0/css/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Roryâ€™s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/womens_health/">womens_health</a></li>
      <li class="active">Abnormal Uterine Bleeding</li>
  </ol>

  <div class="page-header">
 
    <h1>Abnormal Uterine Bleeding</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Abnormal Uterine Bleeding</strong></a>
          <div class="toc">
<ul>
<li><a href="#summary">Summary:</a></li>
<li><a href="#introduction">Introduction:</a><ul>
<li><a href="#classification">Classification</a><ul>
<li><a href="#abnormal-rhythm">Abnormal Rhythm</a></li>
<li><a href="#abnormal-amount">Abnormal amount</a></li>
<li><a href="#combination-rhythm-and-amount">Combination (rhythm and amount)</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#defining-normal-and-abnormal">Defining normal and abnormal</a></li>
<li><a href="#menorrhagia">Menorrhagia</a></li>
<li><a href="#diagnostic-strategy-model">Diagnostic strategy model:</a><ul>
<li><a href="#probability-diagnosis">Probability diagnosis</a></li>
<li><a href="#serious-disorders-not-to-be-missed">Serious disorders not to  be missed</a></li>
<li><a href="#pitfalls">Pitfalls</a></li>
<li><a href="#7-masquerades">7 masquerades:</a></li>
<li><a href="#is-the-patient-trying-to-tell-me-something">Is the patient trying to tell me something?</a></li>
<li><a href="#history">History</a></li>
<li><a href="#examination">Examination</a></li>
<li><a href="#investigations">Investigations</a></li>
</ul>
</li>
<li><a href="#dysfunctional-uterine-bleeding">Dysfunctional uterine bleeding</a><ul>
<li><a href="#clinical-features">Clinical features</a></li>
<li><a href="#symptoms">Symptoms</a></li>
<li><a href="#management">Management</a></li>
<li><a href="#treatment">Treatment</a><ul>
<li><a href="#regimens">Regimens:</a><ul>
<li><a href="#nsaids">NSAIDs:</a></li>
<li><a href="#antifibrinolytics">Antifibrinolytics</a></li>
<li><a href="#coc">COC</a></li>
<li><a href="#progestogens-anovulatory">Progestogens (anovulatory)</a></li>
</ul>
</li>
<li><a href="#typical-treatments">Typical treatments:</a><ul>
<li><a href="#acute-heavy">Acute Heavy</a></li>
<li><a href="#chronic-bleeding">Chronic bleeding</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li><a href="#cycle-irregularity">Cycle irregularity</a><ul>
<li><a href="#patients-35yo">Patients \&lt;35yo</a></li>
<li><a href="#patients-6235yo">Patients >35yo</a></li>
</ul>
</li>
<li><a href="#intermenstrual-bleeding-and-postcoital-bleeding">Intermenstrual bleeding and postcoital bleeding</a></li>
<li><a href="#uterine-fibroids-leiomyoma">Uterine fibroids (leiomyoma)</a><ul>
<li><a href="#clinical-features_1">Clinical features:</a></li>
<li><a href="#symptoms-esp-if-large">Symptoms (esp. if large)</a></li>
<li><a href="#other-features">Other features:</a></li>
<li><a href="#examination_1">Examination</a></li>
<li><a href="#investigations_1">Investigations</a></li>
<li><a href="#management_1">Management</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <p>NICE Pathway1</p>
<p>Patient leaflet - Menorrhagia - patient.co.uk2</p>
<p>Patient leaflet - Surgical options - patient.co.uk3</p>
<p>Patient leaflet - Period blood loss chart - patient.co.uk4</p>
<h3 id="summary">Summary:</h3>
<ul>
<li>
<p>Common</p>
</li>
<li>
<p>Probability diagnosis</p>
<ul>
<li>
<p>Dysfunctional uterine bleeding</p>
</li>
<li>
<p>Fibroids</p>
</li>
<li>
<p>Complication hormone therapy</p>
</li>
<li>
<p>Adenomyosis</p>
</li>
</ul>
</li>
<li>
<p>Rule out</p>
<ul>
<li>
<p>Malignancy - any genital tract</p>
</li>
<li>
<p>Pregnancy</p>
</li>
</ul>
</li>
<li>
<p>Investigations</p>
<ul>
<li>
<p>FBC</p>
</li>
<li>
<p>USS</p>
</li>
</ul>
</li>
<li>
<p>Management</p>
<ul>
<li>
<p>NSAIDs</p>
<ul>
<li>Naproxen 500mg stat then 250mg tds</li>
</ul>
</li>
<li>
<p>TXA</p>
<ul>
<li>Tranexamic acid 1g aid - d1-4 of menstruation</li>
</ul>
</li>
<li>
<p>COC</p>
<ul>
<li>
<p>Standard COC (150/30)</p>
<ul>
<li>tricycle</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Progestogens (anovulatory)</p>
<ul>
<li>
<p>Norethisterone 5-15mg/day for 14 days </p>
<ul>
<li>luteal 15-28d</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Mirena</p>
<ul>
<li>
<p>PHARMAC criteria (ALL)</p>
<ul>
<li>
<p>Clinical diagnosis</p>
</li>
<li>
<p>Failed to respond/unable to tolerate pharmacological therapies</p>
</li>
<li>
<p>Serum ferritin \&lt;16</p>
</li>
<li>
<p>Haemoglobin \&lt;120</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="introduction">Introduction:</h3>
<ul>
<li>
<p>Common problem</p>
</li>
<li>
<p>Heavy menstural bleeding commonest cause of iron-def anaemia in western world</p>
</li>
<li>
<p>20% women in reproductive age c/o inc. menstrual loss</p>
</li>
<li>
<p>4% of GP consults</p>
</li>
<li>
<p>50% of patients with perceived menorrhagia have normal blood loss when investigated</p>
</li>
<li>
<p>Possibility of pregnancy + complications kept in mind</p>
<ul>
<li>
<p>ectopic</p>
</li>
<li>
<p>abortion (threatened, complete or incomplete)</p>
</li>
<li>
<p>hydatidiform mole</p>
</li>
<li>
<p>choriocarcinoma</p>
</li>
</ul>
</li>
<li>
<p>Mean blood loss \&lt;80mL (usually)</p>
</li>
<li>
<p>Menstrual record useful way to calculate blood loss</p>
</li>
<li>
<p>Common = </p>
<ul>
<li>
<p>fibroids</p>
</li>
<li>
<p>adenomyosis (endometrium in uterine myometrium)</p>
</li>
</ul>
</li>
<li>
<p>Consider drugs</p>
</li>
</ul>
<h4 id="classification">Classification</h4>
<h5 id="abnormal-rhythm">Abnormal Rhythm</h5>
<ul>
<li>
<p>Irregularity of cycle</p>
</li>
<li>
<p>intermenstrual bleeding </p>
<ul>
<li>metrorrhagia</li>
</ul>
</li>
<li>
<p>Postcoital bleeding</p>
</li>
<li>
<p>Postmenopausal bleeding</p>
</li>
</ul>
<h5 id="abnormal-amount">Abnormal amount</h5>
<ul>
<li>
<p>Inc. amount = menorrhagia</p>
<ul>
<li>'>80mL per menstruation</li>
</ul>
</li>
<li>
<p>Decreased amount = hypomenorrhoea</p>
</li>
</ul>
<h5 id="combination-rhythm-and-amount">Combination (rhythm and amount)</h5>
<ul>
<li>
<p>Irregular and heavy</p>
<ul>
<li>metromenorrhagia</li>
</ul>
</li>
<li>
<p>Irregular and light periods</p>
<ul>
<li>oligomenohhoea</li>
</ul>
</li>
</ul>
<h3 id="defining-normal-and-abnormal">Defining normal and abnormal</h3>
<ul>
<li>
<p>Based on history, physiology and pathophys</p>
</li>
<li>
<p>Most girls reach menarche @ age 13 (10-16yo)</p>
</li>
<li>
<p>Dysfunctional bleeding common first 2-3 years</p>
<ul>
<li>many anovulatory cycles -> irregular periods, heavy menses and dysmoenorrhoea (prob.)</li>
</ul>
</li>
<li>
<p>Once ovulation and regular menstruation are established -> predictable pattern</p>
<ul>
<li>any deviation = abN</li>
</ul>
</li>
<li>
<p>Normal</p>
<ul>
<li>
<p>Length = 26-28d (21-35d)</p>
</li>
<li>
<p>Menstrual flow = 3-4d (2-7d)</p>
</li>
<li>
<p>Normal blood loss = 30-40mL (20-80mL)</p>
</li>
</ul>
</li>
<li>
<p>AbN is </p>
<ul>
<li>
<p>cycle \&lt;21d</p>
</li>
<li>
<p>Duration of loss >8d</p>
</li>
<li>
<p>volume of loss = pads cannot cope with flow or clots</p>
</li>
</ul>
</li>
<li>
<p>Normal endometrial thickness (USS) = 6-12mm</p>
</li>
<li>
<p>Cycle ovulatory if serum progesterone (corpus luteum) >20nmol/L during mid-luteal phase (5-10d before menses)</p>
</li>
</ul>
<p>++NORMAL PHYSIOLOGY/CYCLE++</p>
<h3 id="menorrhagia">Menorrhagia</h3>
<blockquote>
<p>excessive blood loss >80mL</p>
</blockquote>
<ul>
<li>
<p>caused by:</p>
<ul>
<li>
<p>hormonal dysfunction (anovulation)</p>
</li>
<li>
<p>excessive local production of prostaglandins in endometrium</p>
</li>
<li>
<p>excessive local fibrinolysis of clot</p>
</li>
<li>
<p>local pathology (fibroids)</p>
</li>
<li>
<p>medical disorder</p>
</li>
</ul>
</li>
<li>
<p>If dysmenorrhoea -> Endometriosis or PID</p>
</li>
<li>
<p>60-80% accuracy can be achieved in clinical assessment</p>
</li>
</ul>
<blockquote>
<p>Most common cause: ovulatory dysfunctional uterine bleeding</p>
<p>Most common organic: fibromyomatas, endometriosis, adenomyosis, endometrial polyps, PID</p>
</blockquote>
<h3 id="diagnostic-strategy-model">Diagnostic strategy model:</h3>
<h5 id="probability-diagnosis">Probability diagnosis</h5>
<ul>
<li>
<p>Dysfunctional uterine bleeding</p>
</li>
<li>
<p>Fibroids</p>
</li>
<li>
<p>Complication hormone therapy</p>
</li>
<li>
<p>Adenomyosis</p>
</li>
</ul>
<h5 id="serious-disorders-not-to-be-missed">Serious disorders not to  be missed</h5>
<ul>
<li>
<p>Disorders of preg.</p>
<ul>
<li>
<p>ectopic</p>
</li>
<li>
<p>abortion/miscarriage</p>
</li>
</ul>
</li>
<li>
<p>Neoplasia</p>
<ul>
<li>
<p>cervical Ca</p>
</li>
<li>
<p>Endometrial Ca</p>
</li>
<li>
<p>Oestrogen-Producing ovarian Ca</p>
</li>
<li>
<p>leukaemia</p>
</li>
<li>
<p>Benign tumours</p>
</li>
</ul>
</li>
<li>
<p>Endometrial hyperplasia</p>
</li>
<li>
<p>PID</p>
</li>
</ul>
<h5 id="pitfalls">Pitfalls</h5>
<ul>
<li>
<p>Genital tract trauma</p>
</li>
<li>
<p>IUCD</p>
</li>
<li>
<p>Adenomyosis/endometriosis</p>
</li>
<li>
<p>Pelvic congestion syndrome</p>
</li>
<li>
<p>SLE</p>
</li>
<li>
<p>Rarities:</p>
<ul>
<li>
<p>endocrine disorders</p>
</li>
<li>
<p>bleeding disorder</p>
</li>
<li>
<p>liver disease</p>
</li>
</ul>
</li>
</ul>
<h5 id="7-masquerades">7 masquerades:</h5>
<ul>
<li>
<p>Depression: association</p>
</li>
<li>
<p>DM: yes</p>
</li>
<li>
<p>Drugs: yes</p>
</li>
<li>
<p>Anaemia: Assoc.</p>
</li>
<li>
<p>Thyroid: yes: hypo</p>
</li>
<li>
<p>Spinal dysfunction: nil</p>
</li>
<li>
<p>UTI: nil</p>
</li>
</ul>
<h5 id="is-the-patient-trying-to-tell-me-something">Is the patient trying to tell me something?</h5>
<ul>
<li>Exaggerated perception</li>
</ul>
<h4 id="history">History</h4>
<ul>
<li>
<p>smoking/psychosocial facts</p>
<ul>
<li>
<p>cigarette smokers 5x more likely to have abN menstrual function</p>
</li>
<li>
<p>impact of bleeding</p>
</li>
</ul>
</li>
<li>
<p>Pregnancy/pregnancy complications</p>
</li>
<li>
<p>trauma of genital tract</p>
</li>
<li>
<p>medical disorders</p>
</li>
<li>
<p>endocrine disorders</p>
</li>
<li>
<p>cancer of genital tract</p>
</li>
<li>
<p>complications of the pill</p>
</li>
</ul>
<h4 id="examination">Examination</h4>
<ul>
<li>
<p>Anaemia r/out</p>
</li>
<li>
<p>bleeding disorder</p>
</li>
<li>
<p>Speculum: ?ulcers (cervical Ca); Polyps</p>
</li>
<li>
<p>Pap smear</p>
</li>
<li>
<p>Bimanual: ?uterine/adnexal tenderness, regularity of uterus</p>
</li>
</ul>
<h4 id="investigations">Investigations</h4>
<ul>
<li>
<p>selected carefully</p>
</li>
<li>
<p>indications:</p>
<ul>
<li>
<p>older patients</p>
</li>
<li>
<p>AbN exams</p>
</li>
<li>
<p>persistent symptoms</p>
</li>
<li>
<p>suspicion of other disease</p>
</li>
</ul>
</li>
<li>
<p>consider:</p>
<ul>
<li>
<p>FBC - exclude anaemia/thrombocytopenia</p>
<ul>
<li>NICE - should be carried out in all women</li>
</ul>
</li>
<li>
<p>Iron studies (ferritin)</p>
</li>
<li>
<p>Hysteroscopy/endometrial sampling</p>
<ul>
<li>
<p>NICE</p>
<ul>
<li>
<p>Persistent</p>
</li>
<li>
<p>Women >45</p>
</li>
<li>
<p>Treatment failure</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Special investigations:</p>
<ul>
<li>
<p>pregnancy testing</p>
</li>
<li>
<p>laparoscopy (endometriosis, pID, other pelvic pathology)</p>
</li>
<li>
<p>serum biochemical screen</p>
</li>
<li>
<p>coagulation screen</p>
</li>
<li>
<p>TFT</p>
</li>
<li>
<p>SLE (ANA)</p>
</li>
</ul>
</li>
<li>
<p>USS</p>
<ul>
<li>
<p>NICE</p>
<ul>
<li>
<p>Uterus is palpable</p>
</li>
<li>
<p>Vaginal examination reveals pelvic mass of uncertain origin</p>
</li>
<li>
<p>Pharmaceutical treatment fails</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="dysfunctional-uterine-bleeding">Dysfunctional uterine bleeding</h3>
<ul>
<li>Diagnosis of exclusion</li>
</ul>
<blockquote>
<p>excessive bleeding, whether heavy, prolonged or frequent, of uterine origin, which is not associated with recognisable pelvic disease, complications of pregnancy or systemic disease</p>
</blockquote>
<h4 id="clinical-features">Clinical features</h4>
<ul>
<li>
<p>Working diagnosis</p>
<ul>
<li>
<p>initial history</p>
</li>
<li>
<p>normal PE</p>
</li>
<li>
<p>normal initial investigations</p>
</li>
</ul>
</li>
<li>
<p>very common</p>
<ul>
<li>10-20% incidence of women at some stage</li>
</ul>
</li>
<li>
<p>Peak incidence late 30s-40s</p>
</li>
<li>
<p>Anovulatory DUB 2 peaks</p>
<ul>
<li>
<p>12-16yo</p>
</li>
<li>
<p>45-55yo</p>
</li>
</ul>
</li>
<li>
<p>Bleeding irregular with spotting, variable monorrhagia</p>
</li>
<li>
<p>serum progesterone and pit hormone (LH+FSH) confirm anovulation</p>
</li>
<li>
<p>40% initial diagnosis of DUB have other pathology</p>
<ul>
<li>fibroids/polyps</li>
</ul>
</li>
</ul>
<h4 id="symptoms">Symptoms</h4>
<ul>
<li>
<p>Heavy bleeding</p>
<ul>
<li>
<p>saturated pads</p>
</li>
<li>
<p>frequent changing</p>
</li>
<li>
<p>accidents</p>
</li>
<li>
<p>flooding </p>
</li>
<li>
<p>clots</p>
</li>
</ul>
</li>
<li>
<p>Prolonged bleeding</p>
<ul>
<li>
<p>menstruration >8d</p>
</li>
<li>
<p>heavy bleeding >4d</p>
</li>
</ul>
</li>
<li>
<p>Frequent bleeding</p>
<ul>
<li>
<p>more than once/21d</p>
</li>
<li>
<p>Pelvic pain and tenderness are not usually prominent</p>
</li>
</ul>
</li>
</ul>
<h4 id="management">Management</h4>
<ul>
<li>
<p>Establish Dx - confirming symptoms and exclude other pathology</p>
</li>
<li>
<p>If no evidence of iron def/anaemia -> conservative management</p>
</li>
<li>
<p>\&lt;35yo medical therapy</p>
</li>
<li>
<p>'>35 hysteroscopy and direct endometrial sample</p>
</li>
</ul>
<h4 id="treatment">Treatment</h4>
<ul>
<li>
<p>First line: fibrinolytic inhibitors or anti prostaglandin agents</p>
<ul>
<li>
<p>given ASAP</p>
</li>
<li>
<p>throughout menses</p>
</li>
<li>
<p>60-80% respond if compliance good</p>
</li>
<li>
<p>ideally start NSAID >4d prior to start of menses</p>
</li>
<li>
<p>should be stopped if not achieved reduced bleeding within 3 menstrual cycles</p>
</li>
</ul>
</li>
<li>
<p>First line: Combined oral contraceptive</p>
<ul>
<li>
<p>both ovulatory and anovulatory</p>
</li>
<li>
<p>20% don't respond</p>
</li>
<li>
<p>use pill with a higher oestrogen dose</p>
<ul>
<li>50mcg cf. 35mcg</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Progestogens</p>
<ul>
<li>
<p>Oral - usually no benefit in ovulatory DUB</p>
</li>
<li>
<p>Adolescent w anovulatory DUB</p>
<ul>
<li>
<p>cyclical oral progestogens - 6/12</p>
</li>
<li>
<p>IM medroxyprogesterone acetate - Depo-provera) will induce amenorrhoea in 50% of users in 1yr</p>
</li>
<li>
<p>Intrauterine progesterone implant (MIRENA) 0 releases 20mcg of levonorgestrel/day -> considerable effectiveness</p>
<ul>
<li>
<p>most efficacious hormone treatments</p>
</li>
<li>
<p>PHARMAC</p>
<ul>
<li>
<p>Clinical diagnosis</p>
</li>
<li>
<p>Failed to respond/unable to tolerate pharmacological therapies</p>
</li>
<li>
<p>Serum ferritin \&lt;16</p>
</li>
<li>
<p>Haemoglobin \&lt;120</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Most effective = Tranexamic acid</p>
<ul>
<li>
<p>endometrial plasminogen activation</p>
</li>
<li>
<p>1g qid for first 4 days of the menstrual cycle commencing at the onset of visible bleeding</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Surgery</p>
<ul>
<li>
<p>If uterus is enlarged</p>
</li>
<li>
<p>12-week gestation (grapefruit)</p>
</li>
<li>
<p>anaemic</p>
</li>
<li>
<p>options:</p>
<ul>
<li>
<p>endometrial ablation/electrodiathermy excision</p>
</li>
<li>
<p>hysterectomy</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h5 id="regimens">Regimens:</h5>
<h6 id="nsaids">NSAIDs:</h6>
<ul>
<li>
<p>Mefenamic acid 500mg tis (4 days prior menses due to end) partially funded</p>
</li>
<li>
<p>Naproxen 500mg stat then 250mg tds</p>
</li>
<li>
<p>Ibuprofen 800mg stat then 400mg q6-8h</p>
</li>
</ul>
<h6 id="antifibrinolytics">Antifibrinolytics</h6>
<ul>
<li>Tranexamic acid 1g aid - d1-4 of menstruation</li>
</ul>
<h6 id="coc">COC</h6>
<ul>
<li>
<p>50mcg oestrogen </p>
<ul>
<li>
<p>microgynon (levonorgestrel 125 + ethinylestradiol 50)</p>
<ul>
<li>epileptics: on enzyme inducing</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Standard COC (150/30)</p>
<ul>
<li>tricycle</li>
</ul>
</li>
</ul>
<h6 id="progestogens-anovulatory">Progestogens (anovulatory)</h6>
<ul>
<li>
<p>Norethisterone 5-15mg/day for 14 days </p>
<ul>
<li>luteal 15-28d</li>
</ul>
</li>
<li>
<p>Medroxyprrogesterone - 20-30mg/day</p>
</li>
<li>
<p>Mirena</p>
<ul>
<li>
<p>PHARMAC criteria (ALL)</p>
<ul>
<li>
<p>Clinical diagnosis</p>
</li>
<li>
<p>Failed to respond/unable to tolerate pharmacological therapies</p>
</li>
<li>
<p>Serum ferritin \&lt;16</p>
</li>
<li>
<p>Haemoglobin \&lt;120</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h5 id="typical-treatments">Typical treatments:</h5>
<h6 id="acute-heavy">Acute Heavy</h6>
<ul>
<li>
<p>Curettage/hysteroscopy</p>
</li>
<li>
<p>IV oestrogen (Premarin) then oral</p>
</li>
<li>
<p>oral high dose progestogens</p>
<ul>
<li>5-10mg 2hourly until bleeding stops then 5mg bd/tds for 14d</li>
</ul>
</li>
</ul>
<h6 id="chronic-bleeding">Chronic bleeding</h6>
<ul>
<li>
<p>Anovulatory women:</p>
<ul>
<li>
<p>cyclical oral progestogens 14d</p>
</li>
<li>
<p>txa</p>
</li>
</ul>
</li>
<li>
<p>Ovulatory</p>
<ul>
<li>
<p>cyclical prostaglandin inhibitor (NSAIDs)</p>
</li>
<li>
<p>ORal contraceptive</p>
</li>
<li>
<p>Antifibrinolytics</p>
</li>
</ul>
</li>
</ul>
<h3 id="cycle-irregularity">Cycle irregularity</h3>
<h4 id="patients-35yo">Patients \&lt;35yo</h4>
<ul>
<li>
<p>Cause usually hormonal</p>
<ul>
<li>
<p>rarely organic</p>
</li>
<li>
<p>keep malignancy in mind</p>
</li>
</ul>
</li>
<li>
<p>Management options:</p>
<ul>
<li>
<p>explanation and reassurance</p>
</li>
<li>
<p>COC pill for better cycle control - any pill can be used</p>
</li>
<li>
<p>POP from day 5-25 cycle</p>
</li>
</ul>
</li>
</ul>
<h4 id="patients-6235yo">Patients >35yo</h4>
<ul>
<li>
<p>refer for investigations for organic pathology</p>
<ul>
<li>endometrial sampling and/or hysteroscopy</li>
</ul>
</li>
</ul>
<h3 id="intermenstrual-bleeding-and-postcoital-bleeding">Intermenstrual bleeding and postcoital bleeding</h3>
<ul>
<li>
<p>Cervical ectropion</p>
</li>
<li>
<p>Cervical polyps</p>
</li>
<li>
<p>IUCD</p>
</li>
<li>
<p>OCP</p>
</li>
</ul>
<blockquote>
<p>intermenstural bleeding should always be investigated</p>
</blockquote>
<p>Cervical ectropion commonly found in women on the pill and post partum can be left untreated unless intolerable bleeding discharge or moderate postcoital bleeding present</p>
<p>Change to <strong>higher oestrogen</strong> pill</p>
<h3 id="uterine-fibroids-leiomyoma">Uterine fibroids (leiomyoma)</h3>
<blockquote>
<p>Benign tumours of smooth muscle of the myometrium</p>
<p>Classification:</p>
<ul>
<li>
<p>subserosal</p>
</li>
<li>
<p>intramural</p>
</li>
<li>
<p>subendometrial</p>
</li>
<li>
<p>intra-uterine</p>
</li>
</ul>
</blockquote>
<ul>
<li>
<p>Oestrogen dependent</p>
</li>
<li>
<p>shrink with oner of menopause</p>
</li>
</ul>
<h4 id="clinical-features_1">Clinical features:</h4>
<ul>
<li>
<p>Present in 30% women >35</p>
</li>
<li>
<p>1/800 develop malignancy</p>
</li>
<li>
<p>Usually asymptomatic</p>
</li>
</ul>
<h4 id="symptoms-esp-if-large">Symptoms (esp. if large)</h4>
<ul>
<li>
<p>Menorrhagia</p>
</li>
<li>
<p>Dysmenorrhoea</p>
</li>
<li>
<p>Pelvic discomfort</p>
</li>
<li>
<p>Bladder dysfunction</p>
</li>
<li>
<p>Pain with torsion of pedunculated fibroid</p>
</li>
<li>
<p>Pain with 'red degeneration' - only in pregnancy:</p>
<ul>
<li>pain, fever, local tenderness</li>
</ul>
</li>
</ul>
<h4 id="other-features">Other features:</h4>
<ul>
<li>
<p>Infertility:</p>
<ul>
<li>
<p>can act like iucd if submucosal</p>
</li>
<li>
<p>calcification</p>
</li>
</ul>
</li>
</ul>
<h4 id="examination_1">Examination</h4>
<ul>
<li>Bulky uterus</li>
</ul>
<h4 id="investigations_1">Investigations</h4>
<ul>
<li>
<p>USS</p>
</li>
<li>
<p>FBC - ?anaemia</p>
</li>
<li>
<p>Uterine biopsy (malignancy suspected)</p>
</li>
</ul>
<h4 id="management_1">Management</h4>
<ul>
<li>
<p>Consider COC</p>
</li>
<li>
<p>GnRH analogues</p>
<ul>
<li>
<p>esp. if >42</p>
</li>
<li>
<p>can shrink fibroids (max 6/12)</p>
</li>
</ul>
</li>
<li>
<p>Surgery</p>
<ul>
<li>
<p>myomectomy</p>
</li>
<li>
<p>Hysteroscopic resection</p>
</li>
<li>
<p>hysterectomy</p>
</li>
<li>
<p>Emobolisation</p>
</li>
</ul>
</li>
</ul>
<p>1:  http://pathways.nice.org.uk/pathways/heavy-menstrual-bleeding/heavy-menstrual-bleeding-overview "NICE pathway"</p>
<p>2:  http://www.patient.co.uk/health/heavy-periods-menorrhagia "Menorrhagia"</p>
<p>3:  http://www.patient.co.uk/health/surgical-treatment-options-for-heavy-vaginal-bleeding</p>
<p>4:  http://www.patient.co.uk/health/Period-Blood-Loss-Chart.htm
end</p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
